In an in vivo study, spontaneously hypertensive rats (SHR) were treated with an angiotensin II (Ang II) type 1 receptor antagonist of candesartan or hydralazine. Untreated SHR progressively developed severe hypertension, and treatment with candesartan or hydralazine decreased blood pressure. Candesartan reduced left ventricular (LV) weight, LV wall thickness, transverse myocyte diameter, the relative amount of V3 myosin heavy chain, and interstitial fibrosis, while treatment with hydralazine slightly prevented an increase in LV wall thickness, but did not exert a significant reduction on other parameters. In an in vitro study, neonatal rat cardiomyocytes were cultured on deformable silicone dishes. Stretching cardiomyocytes activated second messengers such as protein kinase C, Raf-1 kinase, and mitogen-activated protein (MAP) kinase, increasing protein synthesis, enhancing endothelin (ET)-1 release,
Introduction
Cardiac hypertrophy, which is a feature of myocardial remodelling in response to high blood pressure, is not only an adaptive process to an increased workload, 1 but also one of the most influential clinical complications. 2 It has been known that a percentage of patients with myocardial hypertrophy develop heart disease, including ischaemic heart disease, heart failure, and sudden cardiac death, and that the hypertrophy is associated with an increase in mortality rate. 2 Elucidation of the underlying mechanisms is, therefore, extremely important. The goal of this article is to focus attention on the triggers for cardiomyocyte hypertrophy induced by hypertension and angiotensin II (Ang II)-induced signalling pathways in both cardiomyocytes and fibroblasts.
Haemodynamic overload and the cardiac renin-angiotensin system
Mechanical overload is a major factor for cardiac hypertrophy at the pressure or volume overload. Although some studies revealed that activation of adrenoceptors accompanies cardiac hypertrophy Correspondence: Tsutomu Yamazaki, Department of Cardiovascular Medicine, Graduate School of Medicine, the University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan activating the Na ؉ /H ؉ ion exchanger. Moreover, pretreatment with candesartan diminished an increase in phenylalanine incorporation, MAP kinase activity, and cfos gene expression induced by the stretching of cardiomyocytes. This suggests that the cardiac reninangiotensin system is linked to the formation of pressure-overload hypertrophy and that Ang II increases the growth of cardiomyocytes by an autocrine mechanism. Finally, we examined the signalling pathways leading to MAP kinase activation both in cardiac myocytes and in cardiac fibroblasts. Ang II-evoked signal transduction pathways differed between cell types. In cardiac fibroblasts, Ang II activated MAP kinase through a pathway including the G␤␥ subunit of Gi protein, Src, Shc, Grb2, and Ras, while Gq and protein kinase C were important in cardiac myocytes.
induced by haemodynamic overload, evidence presented below suggests that mechanical stretch per se is an initial factor for the hypertrophy. Peterson was the first to report that stretch of quiescent papillary muscle accelerates protein synthesis. 3 It was subsequently shown that elevation of aortic pressure increases protein synthesis in beating-perfused hearts. 4 In addition, Cooper et al 5 reported that in aorta-constricted cats, papillary muscle whose tendon has been cut to release tension does not represent hypertrophy, whereas neighbouring uncut papillary muscle shows marked hypertrophy, and that cardiac hypertrophy is induced by pressure overload even under the denervation of ventricular adrenoceptors. Furthermore, stretching cultured cardiomyocytes drastically induced protein synthesis and specific gene expression even without the participation of neural and humoral factors. 6, 7 Much evidence demonstrates that the cardiac renin-angiotensin system is linked to the formation of pressure-overload hypertrophy. It has been shown that all components of the renin-angiotensin system (eg, renin, angiotensinogen, angiotensin-converting enzyme [ACE] , and Ang II receptors) are identified in the heart at both the mRNA and the protein levels, 8 and that the renin-angiotensin system is activated in experimental left ventricular (LV) hypertrophy induced by haemodynamic overload. [8] [9] [10] [11] Shyu et al 12 have also shown that cyclical stretch of cardiac myocytes accelerates angiotensinogen gene expression. Moreover, an increase in LV mass produced by abdominal aortic constriction can be completely prevented by an ACE inhibitor without changes in afterload and plasma renin activity. 13 We further investigated the relation between hypertensive cardiac hypertrophy and the cardiac reninangiotensin system. 14 In an in vivo study, spontaneously hypertensive rats (SHR) were assigned to the treatment with a nonpeptide Ang II type 1 receptor antagonist of candesartan or a vasodilating agent of hydralazine. Blood pressure was measured by a tail cuff method, and the wall thickness of the left ventricle was serially monitored using M-mode echocardiography. LV weight, the transverse diameter of cardiomyocytes, the relative amount of V3 myosin heavy chain (MHC), and the degree of interstitial collagen accumulation were examined. Untreated SHR progressively developed severe hypertension with increasing age, and treatment with candesartan or hydralazine blunted the increase in blood pressure. Treatment with candesartan ameliorated LV weight, LV wall thickness, transverse diameter of myocytes, the relative amount of V3 MHC, and interstitial fibrosis, whereas treatment with hydralazine slightly prevented an increase in LV wall thickness but did not exert significant restorative properties on other indices. These results suggest a crucial role of the cardiac renin-angiotensin system in the development of LV hypertrophy by pressure overload.
To further gain insight into the role of Ang II in mechanical stress-induced cardiac hypertrophy, cardiac myocytes were stretched in the absence or presence of saralasin (an antagonist of Ang II type 1 and type 2 receptors), candesartan, or PD123319 (an Ang II type 2 receptor-specific antagonist). 15 Stretching cardiac myocytes rapidly increased the activities of Raf-1 kinase and MAP kinase. Both saralasin and candesartan partly inhibited the stretch-induced increase in the activities of both kinases, whereas PD123319 was without inhibitory effects. Stretching cardiac myocytes increased amino acid incorporation, which was also partly diminished by pretreatment with saralasin or candesartan. When the culture medium was conditioned by stretching, and the medium was transferred to unstretched cardiac myocytes, the increase in MAP kinase activity was slightly enhanced, and this increase was completely suppressed by saralasin or candesartan. Taken collectively, the locally activated renin-angiotensin system plays a pivotal role in pressure-overload cardiac hypertrophy, and Ang II may act to promote the growth of cardiomyocytes by an autocrine or paracrine mechanism. In fact, the recent in vitro study has shown that mechanical stretch induces secretion of Ang II from cardiac myocytes of neonatal rats. 16 With regard to the molecular mechanisms by which external load evokes cardiac hypertrophy, protein kinase cascades are the focus of much attention. 17 Some groups, including ours, have shown that the mechanical stretch of neonatal rat cardiomyocytes activates second messengers, such as phosphatidylinositol, protein kinase C (PKC), Raf-1 kinase, and MAP kinase, which are involved in the re-expression of a number of genes, including atrial natriuretic peptide, skeletal ␣ actin, and ␤ MHC followed by an increase in protein synthesis. 6, 7, [18] [19] [20] Other humoral factors associated with pressureoverload cardiac hypertrophy
Transforming growth factor-␤ (TGF␤) mRNA levels have been reported to be increased in rat hearts pressure-overloaded by aortic banding. 21 Since the increase is recognised 12 h after banding, it is unlikely that TGF␤ is an initial mediator for a variety of events induced by mechanical stress. On the contrary, we have recently elucidated the association of endothelin-1 (ET-1) with mechanical stretch-induced hypertrophic responses. 22 BQ123, an antagonist selective for the ETA receptor subtype, diminished stretch-induced activation of MAP kinase and an increase in phenylalanine uptake by approximately 60% and 50%, respectively, but an ETB receptor-specific antagonist, BQ788, did not. ET-1 was constitutively secreted from cardiomyocytes, and a significant increase in ET-1 concentration was observed in the culture medium of cardiomyocytes in response to stretch for 10 min. After 24 h, an approximately three-fold increase in ET-1 concentration was recognised in the conditioned medium of stretched cardiomyocytes compared with that of unstretched cardiomyocytes. ET-1 mRNA levels were also increased at 30 min after stretch. Moreover, ET-1 and Ang II synergistically activated Raf-1 kinase and MAP kinase in cardiac myocytes. These results suggest that not only Ang II, but also ET-1 modulates mechanical stress-induced cardiac hypertrophy.
Many cells rapidly respond to a variety of environmental stimuli by ion channels or exchangers in the plasma membrane. Mechanosensitive ion channels have been observed with singlechannel recordings in more than 30 cell types of prokaryotes, plants, fungi, and all animals so far examined. 23 The activation of mechanosensitive ion channels has been proposed as the transduction mechanism between load and protein synthesis in cardiac hypertrophy. 24 When cardiomyocytes were exposed to a Na + ionophore, c-fos expression was induced, possibly because of increased Ca 2+ uptake by the Na + /Ca 2+ exchange mechanism. 21 However, the expression of fetal-type genes were not induced by Na + increase (unpublished data). Conversely, we have recently indicated that the Na + /H + exchanger mediates mechanical stretch-induced hypertrophic responses, such as Raf-1 kinase and MAP kinase activation followed by increased protein synthesis in cardiomyocytes. 25, 26 To determine whether mechanosensitive ion channels and exchangers are involved in stretch-induced hypertrophic responses, cardiomyocytes were stretched after pretreatment with a specific inhibitor of stretch-sensitive cation channels (gadolinium and streptomycin), of ATPsensitive K + channels (glibenclamide), of hyperpolarization-activated inward channels (CsCl), or of the Na + /H + exchanger (HOE 694). Gadolinium, streptomycin, glibenclamide, and CsCl did not show any inhibitory effects on MAP kinase activation by mechanical stretch. HOE 694, however, markedly diminished stretch-induced activation of Raf-1 kinase and MAP kinase by approximately 50% and 60%, respectively, and attenuated stretch-induced increase in phenylalanine incorporation into proteins. Furthermore, the Na + /H + exchanger inhibitor HOE 694, in combination with an Ang II type 1 receptor antagonist candesartan and an ETA receptor antagonist BQ123, almost completely suppressed mechanical stretch-induced MAP kinase activation. Taken collectively, the Na + /H + exchanger and vasoactive peptides such as Ang II and ET-1, released via autocrine pathways, represent at least two different signalling pathways by which mechanical stretch can activate MAP kinase leading to cardiomyocyte hypertrophy (Figure 1 ).
Extracellular matrix and cytoskeleton
There are many data indicating that mechanical stress is transduced into the cell from the sites at which cells attach to extracellular matrix (ECM). 27 Therefore, transmembrane ECM receptors, such as the integrin family adhesion molecules, are good candidates for mechanoreceptors. A large extracellular domain of integrin receptor complex binds to various ECM proteins, while a short cytoplasmic domain interacts with the cytoskeleton in the cell. 28 Integrins, which are heterodimeric proteins composed of ␣ and ␤ subunits, can transmit signals not only by organising the cytoskeleton but also by altering biochemical properties such as the extent of tyrosine phosphorylation of a complex of proteins, including pp125 FAK . 27 In addition, since cytoskeleton proteins can potentially regulate plasma membrane proteins such as enzymes, ion channels, and antiporters, mechanical stress could modulate these membrane-associated proteins and stimulate second-messenger systems through the cytoskeleton. In this regard, the integrin-linked focal adhesion kinase pp125 FAK has been reported to exhibit extracellular matrix-dependent phosphorylation on tyrosine and to physically associate with nonreceptor protein kinases via their Src homology 2 domains. 29 Furthermore, the Rho family small GTPbinding proteins, which play a key part in regulating Figure 1 Model for stretch-induced cardiac hypertrophy. Mechanical stress produced by tension (physical stretching) stimulates secretion of Ang II (angiotensin II) and ET-1 (endothelin-1) from cardiac myocytes. The secretion then activates a protein kinase cascade of phosphorylation and produces cardiac hypertrophy. Furthermore, the Na + /H + exchanger directly activated by mechanical stretch also modulates cardiac hypertrophy.
the actin cytoskeleton and cell adhesion through the integrin receptors, are activated in stretched cardiocytes independently of Ang II and ET-1, the latter two being released in an autocrine manner (unpublished data). These results suggest that mechanical stress is first received by integrin, and that next interlinked actin microfilaments transduce mechanical stress in concert with microtubules and intermediated filaments.
Ang II-induced signal transduction pathways
Ang II directly induces cardiomyocyte hypertrophy even without an increase in vascular resistance or cardiac afterload. 10 We examined Ang II-evoked signal transduction pathways leading to activation of MAP kinase in cardiac myocytes by using a variety of inhibitors. 30 Inhibition of PKC with calphostin C or downregulation of PKC by pretreatment with a phorbol ester for 24 h abolished Ang II-induced activation of Raf-1 kinase and MAP kinase. By contrast, pretreatment with tyrosine kinase inhibitors, genistein and tyrphostin, did not attenuate Ang IIinduced activation of MAP kinase. Overexpression of Csk, which inhibits the function of Src family tyrosine kinases, had no effect on Ang II-induced activation of transfected MAP kinase in cardiac myocytes. Although pretreatment with manumycin, a Ras farnesyltransferase inhibitor, or overexpression of a dominant negative (DN) mutant of Ras, inhibited insulin-induced MAP kinase activation, neither affected Ang II-induced activation of MAP kinase. To the contrary, overexpression of a DN mutant of Raf-1 kinase completely suppressed MAP kinase activation by Ang II. These results, together with the previous data, 20 indicate that Ang II induces cardiomyocyte hypertrophy through the PKC-Raf-1 kinase-MAP kinase cascade.
It has been known that Ang II also evokes a variety of signals and induces proliferation of cardiac fibroblasts. 31 We have recently shown that unlike in cardiac myocytes, Ang II-induced MAP kinase activation is suppressed by tyrosine kinase inhibitors but is not affected by PKC downregulation in cardiac fibroblasts. 32 Ang II-induced MAP kinase activation was abolished by pretreatment with pertussis toxin and by overexpression of the G␤␥ subunit-binding domain of the ␤-adrenergic receptor kinase 1 in cardiac fibroblasts. Inhibition of tyrosine kinases but not of PKC abolished Ang II-induced MAP kinase activation in cardiac fibroblasts. Overexpression of Csk or DN mutant of Ras completely suppressed the activation of MAP kinase in cardiac fibroblasts. Ang II rapidly induced phosphorylation of Shc and association of Shc with Grb2 adapter protein in cardiac fibroblasts but not in cardiac myocytes. These findings suggest that Ang II-evoked signal transduction pathways differ among cell types. In cardiac fibroblasts, Ang II activates MAP kinases through a pathway including the G␤␥ subunit of Gi protein, tyrosine kinases including Src family tyrosine kinases, Shc, Grb2, Ras, and Raf-1 kinase; while Gq and PKC are important in cardiac myocytes (Figure 2 ).
Figure 2
Signalling pathways induced by Ang II. In cardiac myocytes, Ang II-induced MAP kinase activation is independent of the ␤␥ subunit of Gi, Src, Shc, Grb2, and Ras, but dependent on PKC (protein kinase C). By contrast, in cardiac fibroblasts, Ang II activates the G␤␥ subunit derived from Gi protein, which in turn leads to the phosphorylation cascade including Src, Shc, Grb2, and Ras followed by activation of the Raf-1 kinase/MAP kinase cascade.
Conclusion
In summary, mechanical stretch-induced Ang II and ET-1 produce cardiac hypertrophy, and the NHE directly activated by mechanical stretch also induces the hypertrophic responses independently of the autocrine release of Ang II and ET-1. Furthermore, Ang II-induced signal transduction pathways leading to MAP kinase activation are divergent among cell types. Acting via the different signalling pathways, Ang II evokes cardiac myocyte hypertrophy and fibroblast proliferation. Further investigation will lead to the development of novel strategies for the prevention and treatment of the hypertensive cardiac hypertrophy and failure.
